Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-26-023804
Filing Date
2026-03-05
Accepted
2026-03-05 07:01:00
Documents
100
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lqda-20251231x10k.htm   iXBRL 10-K 2661853
2 EX-10.11 lqda-20251231xex10d11.htm EX-10.11 8289
3 EX-10.12 lqda-20251231xex10d12.htm EX-10.12 21022
4 EX-10.13 lqda-20251231xex10d13.htm EX-10.13 18493
5 EX-10.14 lqda-20251231xex10d14.htm EX-10.14 24871
6 EX-10.55 lqda-20251231xex10d55.htm EX-10.55 579149
7 EX-21.1 lqda-20251231xex21d1.htm EX-21.1 4028
8 EX-23.1 lqda-20251231xex23d1.htm EX-23.1 4664
9 EX-31.1 lqda-20251231xex31d1.htm EX-31.1 14150
10 EX-31.2 lqda-20251231xex31d2.htm EX-31.2 13376
11 EX-32.1 lqda-20251231xex32d1.htm EX-32.1 6435
12 EX-32.2 lqda-20251231xex32d2.htm EX-32.2 6385
13 GRAPHIC lqda-20251231x10k001.jpg GRAPHIC 28042
14 GRAPHIC lqda-20251231x10k002.jpg GRAPHIC 39451
15 GRAPHIC lqda-20251231xex10d12002.jpg GRAPHIC 739
16 GRAPHIC lqda-20251231xex10d13001.jpg GRAPHIC 739
17 GRAPHIC lqda-20251231xex10d14001.jpg GRAPHIC 739
  Complete submission text file 0001104659-26-023804.txt   12198842

Data Files

Seq Description Document Type Size
18 EX-101.SCH lqda-20251231.xsd EX-101.SCH 77102
19 EX-101.CAL lqda-20251231_cal.xml EX-101.CAL 74587
20 EX-101.DEF lqda-20251231_def.xml EX-101.DEF 265599
21 EX-101.LAB lqda-20251231_lab.xml EX-101.LAB 688128
22 EX-101.PRE lqda-20251231_pre.xml EX-101.PRE 460210
103 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20251231x10k_htm.xml XML 2055285
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39724 | Film No.: 26724151
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)